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inear IgA bullous dermatosis (LABD) is an
autoimmune subepidermal vesiculobullous
disease. The exact cause of LABD is unknown,
but there are many associated conditions that
have been reported in the literature, including
medications, gastrointestinal diseases, autoimmune
diseases, infections, and malignancies, including
lymphoma.1-5CASE REPORT
A 46-year-old man presented with a 1-year history
of recurrent rash and painful mouth sores. On
physical examination, he had widespread, scattered,
arcuate and annular erythematous macules and ur-
ticarial plaques over his trunk and extremities (Fig 1),
and numerous oral vesicles and perioral superficially
eroded papules. His medical history was significant
for gastroesophageal reflux disease, bleeding stom-
ach ulcers, a photoexacerbated rash 1 year prior, a
severe herpes zoster infection of the head and neck
6 months before presentation, unexplained weight
loss of 15 to 18 lb over the last year, and an outside
complete blood cell count with mild atypical
lymphocytosis. He had no history of inflammatory
bowel disease or autoimmune disease. He reported
night sweats and fatigue, but denied headaches,
fevers, chills, abdominal pain, nausea, vomiting, and
diarrhea. His only medications were omeprazole and
acetaminophen of which he had been taking 500 mgLahey Hospital and Medical Center, Burlingtona; Dartmouth-
tchcock Medical Center, Lebanonb; and Oregon Health and
ience University.c
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freybtigermd@gmail.com.every 4 to 6 hours for about 2 months for what was
believed to be postherpetic neuralgia.
A biopsy specimen showed a subepidermal ve-
sicular dermatitis with numerous neutrophils ex-
tending along the dermoepidermal junction (Fig 2).
A repeated biopsy specimen for direct immunofluo-
rescence showed linear IgA deposition at the base-
ment membrane zone, consistent with the diagnosis
of LABD (Fig 3). IgG, complement component 3,
IgM, fibrin, and albumin were negative. There was
no evidence of malignancy in either biopsy spec-
imen. The patient had no concern for infection. A
rapid stain for herpes simplex and varicella zoster
viruses and a herpes simplex virus culture revealed
negative findings. The patient had also been treated
empirically with a course of cephalexin and acyclovir
during active disease but did not improve with either
treatment.
The origin of the LABD was unclear; however, his
history of weight loss, fatigue, night sweats, severe
herpes zoster infection 6 months prior, and lympho-
cytosis were concerning for an underlying malig-
nancy. Therefore, further workup was performed.
Complete blood cell count showed an elevated
absolute lymphocyte count (5.85 k/L; normal range
is 1.0-4.80 k/L) with atypical lymphocytes and
normal hemoglobin and platelet count. Flow
cytometry of peripheral blood showed monoclonal
k-restricted CD51/CD191/CD201/CD231/CD381/
zeta-chain (T-cell receptor)-associated proteinJAAD Case Reports 2015;1:412-4.
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Fig 1. Clinical presentation, left flank: annular erythema-
tous urticarial plaque.
Fig 2. Initial biopsy specimen for hematoxylin-eosin:
subepidermal vesicular dermatitis with numerous neutro-
phils extending along the dermoepidermal junction.
Fig 3. Repeated biopsy specimen for direct immunofluo-
rescence: linear IgA deposition present at the basement
membrane zone, consistent with the diagnosis of linear
IgA bullous dermatosis.
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diagnosis of chronic lymphocytic leukemia (CLL). A
computed tomography scan of chest, abdomen, and
pelvis showed diffuse lymphadenopathy. A bone-
marrow biopsy specimen demonstrated a normocel-
lular marrow with maturing trilineage hematopoiesis
and nodular and interstitial lymphoid aggregates
comprising 5% to 40% of total cellularity.
Fluorescent in situ hybridization was positive for
trisomy 12.Once given a diagnosis of LABD, the patient was
instructed to discontinue all medications to rule out
drug-induced LABD. Despite refraining from these
medications for over 3 months, the patient continued
to manifest new skin lesions.
The patient was treated with fludarabine and
rituximab. His night sweats and fatigue resolved
after 2 treatment cycles. After 6 cycles of chemo-
therapy, he achieved partial remission of his CLL and
complete resolution of his LABD. Since resolution of
his LABD, the patient has taken both omeprazole and
acetaminophen with no evidence of LABD
recurrence.
DISCUSSION
The underlying mechanism responsible for
LABD in this case is unclear, but it is thought to
most likely be a result of his underlying CLL. CLL
may be associated with other bullous dermatoses,
including bullous pemphigoid, paraneoplastic
eruptions (including rare reports of IgA-mediated
disease), and exaggerated bite-type reactions.3
There has been 1 other reported case of LABD
associated with CLL.4 That patient presented simi-
larly to ours, with large areas of urticated annular
erythema in the axillae and over the trunk.
However, that patient had already been given a
diagnosis of CLL and received 2 months of treat-
ment with chlorambucil and allopurinol before the
onset of LABD. Furthermore, the mucous mem-
branes of the mouth and eyes were not involved in
that case.
In summary, to our knowledge, this is the second
reported case of paraneoplastic LABD associated
with CLL, and the first to have LABD as a presenting
sign. Furthermore, this patient presented atypically,
with annular urticarial plaques, oral vesicles, and
perioral eroded papules, rather than the classic
lesions of vesicles or bullae arranged in a ‘‘crown
of jewels’’ pattern. It has been reported that drug-
induced LABD is more severe than spontaneous
form.5 In our case, the paraneoplastic form also
presented severely, although generalizations cannot
bemade from this 1 case. Clinicians need to be aware
of these rare paraneoplastic skin dermatoses to
establish proper diagnosis and treatment of the
underlying conditions, which may lead to resolution
of not only the underlying disease, but the skin
manifestations as well.
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